2022 Publications

N Mullins, JE Kang, AI Campos, JRI Coleman, AC Edwards, H Galfalvy, .... Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders, and known risk factors. Biological psychiatry. 91 (3), 313-327. 2022.

GAM Blokland, J Grove, CY Chen, C Cotsapas, S Tobet, R Handa, .... Sex-dependent shared and nonshared genetic architecture across mood and psychotic disorders. Biological psychiatry. 91 (1), 102-117. 2022.

J Ren, W Pang, Y Luo, D Cheng, K Qiu, Y Rao, Y Zheng, Y Dong, J Peng, .... Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality. The Journal of Allergy and Clinical Immunology: In Practice. 10 (1), 124-133. 2022.

AR Zlotta, LK Ballas, A Niemierko, K Lajkosz, C Kuk, G Miranda, .... Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle-invasive bladder cancer.. Journal of Clinical Oncology. 40 (6_suppl), 433-433. 2022.

J Tran, D Sharma, N Gotlieb, W Xu, M Bhat. Application of machine learning in liver transplantation: A review. Hepatology International. 1-14. 2022.

SR Kim, S Laframboise, G Nelson, SA McCluskey, L Avery, N Kujbid, .... Enhanced recovery after minimally invasive gynecologic oncology surgery to improve same day discharge: a quality improvement project. International Journal of Gynecologic Cancer. 32 (4). 2022.

A Das, S Sudhaman, D Morgenstern, A Coblentz, J Chung, SC Stone, .... Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. Nature medicine. 28 (1), 125-135. 2022.

S Myrehaug, J Hudson, H Soliman, M Ruschin, CL Tseng, J Detsky, .... Hypofractionated Stereotactic Radiation Therapy for Intact Brain Metastases in 5 Daily Fractions: Effect of Dose on Treatment Response. International Journal of Radiation Oncology* Biology* Physics. 112 (2), 342-350. 2022.

B Chen, W Xu. Functional response regression model on correlated longitudinal microbiome sequencing data. Statistical Methods in Medical Research. 31 (2), 361-371. 2022.

S Orzell, BFJ Verhaaren, R Grewal, M Sklar, JC Irish, R Gilbert, D Brown, .... Evaluation of Sarcopenia in older patients undergoing head and neck cancer surgery. The Laryngoscope. 132 (2), 356-363. 2022.

J Ren, W Pang, K Hueniken, G Haddad, A Hope, SH Huang, A Spreafico, .... Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers. Cancer. 128 (3), 497-508. 2022.

D Chahal, D Sharma, S Keshavarzi, FAQ Arisar, K Patel, W Xu, M Bhat. Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank. Hepatology International. 16 (2), 325-336. 2022.

P Lassen, SH Huang, J Su, J Waldron, M Andersen, H Primdahl, .... Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts. International Journal of Cancer. 150 (8), 1329-1340. 2022.

R Rodin, N Swami, A Pope, D Hui, B Hannon, LW Le, C Zimmermann. Impact of early palliative care according to baseline symptom severity: Secondary analysis of a cluster-randomized controlled trial in patients with advanced cancer. Cancer medicine. 11 (8), 1869-1878. 2022.

BE Swift, L Philp, EG Atenafu, N Malkani, LT Gien, MQ Bernardini. Lymphadenectomy for high-grade endometrial cancer: Does it impact lymph node recurrence?. European Journal of Surgical Oncology. 48 (5), 1181-1187. 2022.

BI Said, L Ailles, C Karamboulas, J Meens, SH Huang, W Xu, .... Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment. JAMA Otolaryngology–Head & Neck Surgery. 148 (4), 342-349. 2022.

JCF Quintanilha, J Wang, AB Sibley, W Xu, O Espin-Garcia, C Jiang, .... Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens. International Journal of Cancer. 150 (2), 279-289. 2022.

MA Ugas, D Samoil, L Avery, A Berlin, ME Giuliani, TJ Papadakos, .... COVID-19 and patients with cancer: Investigating treatment impact, information sources, and COVID-19–related knowledge, attitudes, and practices. Cancer. 128 (4), 746-761. 2022.

MR Downes, K Lajkosz, C Kuk, B Gao, GS Kulkarni, TH van der Kwast. The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes. Pathology. 54 (4), 425-433. 2022.

A Basso Dias, A Finelli, G Bauman, P Veit-Haibach, A Berlin, C Ortega, .... Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer. Radiology. 211836. 2022.

NE Fleshner, AR Hansen, J Chin, E Winquist, T Van Der Kwast, K Lajkosz, .... Randomized phase II trial of neoadjuvant abiraterone plus or minus cabazitaxel in high-risk prostate cancer: ACDC-RP.. Journal of Clinical Oncology. 40 (6_suppl), 224-224. 2022.

R Anconina, C Ortega, U Metser, ZA Liu, C Suzuki, M McInnis, GE Darling, .... Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 49 (3), 1012-1020. 2022.

AP Hapsari, JW Ho, C Meaney, L Avery, N Hassen, A Jetha, AM Lay, .... The working conditions for personal support workers in the Greater Toronto Area during the COVID-19 pandemic: a mixed-methods study. Canadian Journal of Public Health. 1-17. 2022.

A Abugharib, KL Zeng, CL Tseng, H Soliman, S Myrehaug, Z Husain, .... Spine stereotactic body radiotherapy for prostate cancer metastases and the impact of hormone sensitivity status on local control. Neurosurgery. 90 (6), 743-749. 2022.

L Fleshner, A Berlin, K Hersey, M Kenk, K Lajkosz, S Nguyen, J Wise, .... Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonists: Implications for remote monitoring. Canadian Urological Association Journal. 16 (3), E146. 2022.

D Sharma, N Gotlieb, ME Farkouh, K Patel, W Xu, M Bhat. Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort. Journal of the American Heart Association. 11 (1), e022576. 2022.

L Xie, Y Ding, D Li, C Zhang, Y Wu, L Sun, M Liu, X Qiu, W Xu. Local Chiral Inversion of Thymine Dimers by Manipulating Single Water Molecules. Journal of the American Chemical Society. 144 (11), 5023-5028. 2022.

DY Mak, Z Siddiqui, ZA Liu, H Dama, SM MacDonald, S Wu, ES Murphy, .... Photon versus proton whole ventricular radiotherapy for non-germinomatous germ cell tumors: A report from the Children's Oncology Group. Pediatric Blood & Cancer, e. e29697. 2022.

MP Gauthier, JH Law, LW Le, JJN Li, S Zahir, S Nirmalakumar, M Sung, .... Automating Access to Real World Evidence. JTO Clinical and Research Reports. 100340. 2022.

SA Ali, O Espin-Garcia, AK Wong, P Potla, C Pastrello, M McIntyre, .... Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort. Therapeutic advances in musculoskeletal disease. 14, 1759720X221082917. 2022.

S Schmid, M Jiang, MC Brown, A Fares, M Garcia, J Soriano, M Dong, .... Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data. Cancer Epidemiology and Prevention Biomarkers. . 2022.

N Perlis, A Finelli, M Lovas, A Lund, A DiMeo, K Lajkosz, A Berlin, .... MP16-10 EXPLORING THE VALUE OF USING PATIENT-ORIENTED MRI REPORTS IN CLINICAL PRACTICE. The Journal of Urology. 207 (Supplement 5), e278. 2022.

Y Qaoud, JO Herrera-Caceres, R Bass, MB Berjaoui, R Tiwari, M Kenk, .... Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes. Urologic Oncology: Seminars and Original Investigations. 40 (7), 343. e1-343. e6. 2022.

M Garcia Pardo, K Czarnecka, JH Law, AM Salvarrey, R Fernandes, J Fan, .... Plasma first: Accelerating lung cancer diagnosis through liquid biopsy.. Journal of Clinical Oncology. 40 (16_suppl), 3039-3039. 2022.

SC Lewis, AJ Hope, M Chan, J Weiss, H Raziee, A Bezjak, J Cho, A Sun, .... FLT-PET/CT in Non-Small Cell Lung Cancer Treated With SBRT-A Pilot Study. International Journal of Radiation Oncology, Biology, Physics. 112 (2), e5-e6. 2022.

AM Sawka, S Ghai, L Rotstein, JC Irish, JD Pasternak, PJ Gullane, .... A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer. Thyroid. 32 (3), 255-262. 2022.

LX Ma, O Espin-Garcia, Y Wang, MJ Allen, GH Jang, A Zhang, A Dodd, .... Comparison of systematic inflammatory prognostic scores in patients with advanced pancreatic adenocarcinoma.. Journal of Clinical Oncology. 40 (16_suppl), 4149-4149. 2022.

D Zhao, M Zarif, E Eladl, JM Capo-Chichi, A CSmith, E Atenafu, A Tierens, .... NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1. Leukemia Research. 106869. 2022.

N Kuehne, K Hueniken, M Xu, S Shakik, A Vedadi, D Pinto, MC Brown, .... Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data. Clinical Lung Cancer. 23 (2), e154-e164. 2022.

SH Huang, JCK Jacinto, B O’Sullivan, J Su, J Kim, J Ringash, A Spreafico, .... Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort. Cancer. . 2022.

E Villegas, C Vitug, K Lajkosz, C Kuk, B Gao, O Hemminiki, D Kot, S Din, .... PD26-05 HOW LONG SHOULD WE FOLLOW LOW GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)? A LARGE RETROSPECTIVE SINGLE INSTITUTION ANALYSIS. The Journal of Urology. 207 (Supplement 5), e489. 2022.

A Neustaeter, J Timpano, S Lee, M Xue, H Leibovitzh, K Madsen, .... A157 DEFINITIONS OF MEDITERRANEAN DIET INCONSISTENTLY ASSOCIATE WITH MARKERS OF GUT BARRIER FUNCTION OR SUBCLINICAL INFLAMMATION IN A POPULATION-BASED COHORT. Journal of the Canadian Association of Gastroenterology. 5 (Supplement_1), 32-33. 2022.

LX Ma, O Espin-Garcia, Y Bach, H Aoyama, MJ Allen, X Wang, GE Darling, .... Comparison of four clinical prognostic scores in patients with advanced gastric and esophageal cancer.. Journal of Clinical Oncology. 40 (16_suppl), 4057-4057. 2022.

O Chin, L Alshafai, B O'Sullivan, J Su, A Hope, E Bartlett, AR Hansen, .... Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma. Oral Oncology. 125, 105716. 2022.

JT England, CJ McNamara, JA Kennedy, JM Capo-Chichi, J Huang, .... Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort. Leukemia. 36 (6), 1689-1692. 2022.

HJ Janse van Rensburg, Z Liu, AR Abdul Razak, A Spreafico, PL Bedard, .... The effect of circadian rhythm on clinical outcome in patients receiving pembrolizumab in the INSPIRE pan-cancer trial.. Journal of Clinical Oncology. 40 (16_suppl), 2589-2589. 2022.

MR Sung, P Tomasini, LW Le, S Kamel-Reid, MS Tsao, G Liu, .... Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection. JTO clinical and research reports. 3 (2), 100259. 2022.

K Yang, E Gutierrez, AP Landry, A Kalyvas, M Millesi, M Leite, .... Multiplicity does not significantly affect outcomes in brain metastasis patients treated with surgery. Neuro-Oncology Advances. . 2022.

PA Jablonska, CH Fong, T Kruser, J Weiss, ZA Liu, H Takami, Y Narita, .... Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice. Radiotherapy and Oncology. 168, 89-94. 2022.

A Veneziani, S Lheureux, H Alqaisi, G Bhat, I Colombo, E Gonzalez, .... Pembrolizumab, maveropepimut-S, and low-dose cyclophosphamide in advanced epithelial ovarian cancer: Results from phase 1 and expansion cohort of PESCO trial.. Journal of Clinical Oncology. 40 (16_suppl), 5505-5505. 2022.